You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Moodys
Colorcon
Baxter
Express Scripts

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Captopril - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for captopril and what is the scope of patent protection?

Captopril is the generic ingredient in seven branded drugs marketed by Par Pharm, Acp Nimble, Ajanta Pharma Ltd, Apothecon, Boscogen, Corepharma, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Mylan, Oxford Pharms, Prinston Inc, Purepac Pharm, Sandoz, Seton Pharms, Teva, Watson Labs, Wockhardt Ltd, Yaopharma Co Ltd, Ivax Sub Teva Pharms, and Vintage Pharms Llc, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for captopril. Thirteen suppliers are listed for this compound.

Drug Prices for captopril

See drug prices for captopril

Recent Clinical Trials for captopril

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assistance Publique - Hôpitaux de ParisPhase 2
Onassis Cardiac Surgery CentreN/A
Ain Shams UniversityPhase 4

See all captopril clinical trials

Pharmacology for captopril
Medical Subject Heading (MeSH) Categories for captopril
Paragraph IV (Patent) Challenges for CAPTOPRIL
Tradename Dosage Ingredient NDA Submissiondate
CAPOTEN TABLET;ORAL captopril 018343

US Patents and Regulatory Information for captopril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074832-001 Dec 29, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Par Pharm CAPTOPRIL captopril TABLET;ORAL 074493-002 Feb 13, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 DISCN Yes No   Start Trial   Start Trial   Start Trial
Hikma Intl Pharms CAPTOPRIL captopril TABLET;ORAL 074505-001 Feb 13, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Prinston Inc CAPTOPRIL captopril TABLET;ORAL 074477-002 Feb 13, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Yaopharma Co Ltd CAPTOPRIL captopril TABLET;ORAL 074363-002 Nov 9, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
Acp Nimble CAPTOPRIL captopril TABLET;ORAL 074483-001 Feb 13, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for captopril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-004 Jun 13, 1995   Start Trial   Start Trial
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-006 Sep 17, 1986   Start Trial   Start Trial
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-005 Jan 17, 1985   Start Trial   Start Trial
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-004 Jun 13, 1995   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Moodys
Colorcon
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.